Get the Stockscreener App
6.25
3.48%
0.21
After Hours:
6.13
-0.12
-1.92%
Lensar Inc stock is traded at $6.25, with a volume of 117.36K.
It is up +3.48% in the last 24 hours and down -36.55% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
See More
Previous Close:
$6.04
Open:
$6.02
24h Volume:
117.36K
Relative Volume:
1.17
Market Cap:
$75.60M
Revenue:
$58.44M
Net Income/Loss:
$-34.28M
P/E Ratio:
-2.1556
EPS:
-2.8994
Net Cash Flow:
$-14.91M
1W Performance:
+13.02%
1M Performance:
-36.55%
6M Performance:
-46.17%
1Y Performance:
-53.70%
1-Day Range:
$6.02
$6.26
1-Week Range:
$5.33
$6.26
52-Week Range:
$5.33
$14.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
6.25 | 73.06M | 58.44M | -34.28M | -14.91M | -2.8994 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Upgrade | Lake Street | Hold → Buy |
| Mar-18-26 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LENSAR Announces Upcoming Chief Financial Officer Transition - TipRanks
LENSAR (LNSR) price target decreased by 16.67% to 12.75 - MSN
Aug Highlights: What are analysts price targets for LENSAR Inc2026 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
LENSAR (LNSR) price target decreased by 32.00% to 8.67 - MSN
Volume Report: Is LENSAR Inc a defensive stock2026 Market WrapUp & Weekly High Conviction Trade Ideas - baoquankhu1.vn
BTIG Upgrades LNSR (LENSAR, Inc.) to Buy March 2026 - Meyka
U.S. Federal Trade Commission – Proposed Merger Between Alcon, Inc. And Lensar, Inc. Abandoned Following Competition Concerns - marketscreener.com
Breakout Watch: Is LENSAR Inc a defensive stockWeekly Loss Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Aug Momentum: Can LENSAR Inc continue delivering strong returns2026 Major Catalysts & Safe Entry Zone Identification - baoquankhu1.vn
Aug Patterns: Should I add LENSAR Inc stock to my portfolio2026 Buyback Activity & Risk Controlled Swing Alerts - baoquankhu1.vn
LENSAR, Inc. (LNSR) Stock Price, News, Quote & History - ca.finance.yahoo.com
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset - Yahoo Finance
Discipline and Rules-Based Execution in LNSR Response - Stock Traders Daily
LENSAR, Inc. (NASDAQ:LNSR) Q4 2025 Earnings Call Transcript - Insider Monkey
LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating G - GuruFocus
LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges By GuruFocus - Investing.com Canada
LENSAR : LNSR Corporate Presentation March 2026 - marketscreener.com
Lensar Faces Heightened Litigation Risk as Shareholders Challenge Merger Disclosures in Delaware - TipRanks
BTIG Upgrades LENSAR, Inc. (LNSR) to Buy March 2026 - Meyka
Investment Recap: Is LENSAR Inc a strong candidate for buy and hold2026 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Lensar Earnings Call: Recurring Revenue Shines Amid Disruption - TipRanks
LNSR SEC FilingsLensar Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Lake Street upgrades Lensar stock rating to buy after merger termination - Investing.com India
Lake Street upgrades Lensar stock rating to buy after merger termination By Investing.com - Investing.com South Africa
LENSAR (NASDAQ:LNSR) Upgraded at Lake Street Capital - MarketBeat
LENSAR, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
LENSAR Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update - bitget.com
LENSAR Reports Strong 2025 Results: ALLY Robotic Cataract Laser Adoption Grows, Recurring Revenue Hits $46.3M - Minichart
LENSAR (LNSR) leans on ALLY robotic cataract laser amid expanding global surgery demand - Stock Titan
Lensar outlines 46%–49% gross margin forecast for 2026 as it restarts growth after Alcon deal termination - MSN
BTIG cuts Lensar stock price target to $7 on weak results - Investing.com Canada
BTIG cuts Lensar stock price target to $7 on weak results By Investing.com - Investing.com South Africa
Alcon Inc Stock Faces Patent Setback and Merger Termination: Key Implications for NYSE:ALC Investors - AD HOC NEWS
Growth Report: Should I average down on LENSAR Inc stockTrade Ideas & High Conviction Buy Zone Picks - baoquankhu1.vn
LENSAR ($LNSR) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
LNSR: Recurring revenue and procedure volumes grew strongly in 2025, with positive adjusted EBITDA - TradingView — Track All Markets
LENSAR Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: LENSAR Q4 2025 results show mixed signals By Investing.com - Investing.com Canada
LENSAR earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: LENSAR Q4 2025 results show mixed signals - Investing.com
LENSAR (NASDAQ:LNSR) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
LENSAR, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Q4 2025 LENSAR Inc Earnings Call Transcript - GuruFocus
LENSAR (LNSR) Advances in Robotic Laser Cataract Surgery with St - GuruFocus
Lensar, Inc. (LNSR) Reports Q4 Earnings - AlphaStreet
LENSAR reports FY2025 revenue $58.4M, recurring revenue $46.3M and 79% recurring mix - TradingView
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update - The Manila Times
Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2025 Result - GuruFocus
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.35 - Markets Mojo
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):